BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15555916)

  • 1. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
    Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
    Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and Treatments in Demyelinating CMT.
    Fridman V; Saporta MA
    Neurotherapeutics; 2021 Oct; 18(4):2236-2268. PubMed ID: 34750751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22.
    Marinko JT; Wright MT; Schlebach JP; Clowes KR; Heintzman DR; Plate L; Sanders CR
    J Biol Chem; 2021; 296():100719. PubMed ID: 33933451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Does Protein Zero Assemble Compact Myelin?
    Raasakka A; Kursula P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32759708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure and function of myelin protein P0 in membrane stacking.
    Raasakka A; Ruskamo S; Kowal J; Han H; Baumann A; Myllykoski M; Fasano A; Rossano R; Riccio P; Bürck J; Ulrich AS; Stahlberg H; Kursula P
    Sci Rep; 2019 Jan; 9(1):642. PubMed ID: 30679613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.
    Poitelon Y; Matafora V; Silvestri N; Zambroni D; McGarry C; Serghany N; Rush T; Vizzuso D; Court FA; Bachi A; Wrabetz L; Feltri ML
    J Neurochem; 2018 May; 145(3):245-257. PubMed ID: 29315582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy.
    Liao YC; Tsai PC; Lin TS; Hsiao CT; Chao NC; Lin KP; Lee YC
    Sci Rep; 2017 Nov; 7(1):15363. PubMed ID: 29127354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral myelin protein 22 alters membrane architecture.
    Mittendorf KF; Marinko JT; Hampton CM; Ke Z; Hadziselimovic A; Schlebach JP; Law CL; Li J; Wright ER; Sanders CR; Ohi MD
    Sci Adv; 2017 Jul; 3(7):e1700220. PubMed ID: 28695207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topologically Diverse Human Membrane Proteins Partition to Liquid-Disordered Domains in Phase-Separated Lipid Vesicles.
    Schlebach JP; Barrett PJ; Day CA; Kim JH; Kenworthy AK; Sanders CR
    Biochemistry; 2016 Feb; 55(7):985-8. PubMed ID: 26859249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling crucial biomechanical resilience of myelinated peripheral nerve fibres provided by the Schwann cell basal lamina and PMP22.
    Rosso G; Liashkovich I; Gess B; Young P; Kun A; Shahin V
    Sci Rep; 2014 Dec; 4():7286. PubMed ID: 25446378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PMP22 gene and its related diseases.
    Li J; Parker B; Martyn C; Natarajan C; Guo J
    Mol Neurobiol; 2013 Apr; 47(2):673-98. PubMed ID: 23224996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice.
    Rangaraju S; Verrier JD; Madorsky I; Nicks J; Dunn WA; Notterpek L
    J Neurosci; 2010 Aug; 30(34):11388-97. PubMed ID: 20739560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PMP22 expression in dermal nerve myelin from patients with CMT1A.
    Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
    Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of Charcot-Marie-Tooth disease type 1A.
    Sereda MW; Nave KA
    Neuromolecular Med; 2006; 8(1-2):205-16. PubMed ID: 16775377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy.
    Meyer zu Hörste G; Prukop T; Nave KA; Sereda MW
    J Mol Neurosci; 2006; 28(1):77-88. PubMed ID: 16632877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina.
    Amici SA; Dunn WA; Murphy AJ; Adams NC; Gale NW; Valenzuela DM; Yancopoulos GD; Notterpek L
    J Neurosci; 2006 Jan; 26(4):1179-89. PubMed ID: 16436605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
    Hasse B; Bosse F; Hanenberg H; Müller HW
    Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
    Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.